Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Hikma Pharmaceuticals Plc (OP: HKMPY )

68.20 USD UNCHANGED
Streaming Delayed Price Updated: 1:55 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Hikma Pharmaceuticals Plc

< Previous 1 2 Next >
Hikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report
Improved rating elevates Hikma to global leadership position 
From PR Newswire
Hikma launches generic Advair Diskus® following FDA approval
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces it has received FDA approval for and launched its generic version of GlaxoSmithKline's Advair Diskus®1... 
From PR Newswire
Sesen Bio Announces Partnership with Hikma Pharmaceuticals for the Commercialization of Vicineum™ in the Middle East and North Africa
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and Hikma Pharmaceuticals, a multi-national... 
From Business Wire News Releases
Hikma and Arecor Expand Collaboration
From GlobeNewswire News Releases
Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
Adds ready-to-administer injectable product to companies' existing partnership 
From PR Newswire
Hikma receives favourable court ruling for its generic Vascepa®
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the... 
From PR Newswire
Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership
Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD. The round was led by MEDTEQ,... 
From PR Newswire
Twitter Looks At Crashing Microsoft’s TikTok Party
Over the weekend it was reported that social media firm Twitter has held initial talks about a possible deal to acquire TikTok’s US operation, something that Microsoft has spent weeks negotiating with... 
Tags Currencies/Forex Energy Consumer Goods
From Blogs - TalkMarkets
Hikma launches Dicyclomine Hydrochloride Oral Solution
Receives first Competitive Generic Therapy Exclusivity from FDA 
From PR Newswire
FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules
The arrival of a generic version of Vascepa will be bad news for the company. 
Tags AMRN Market News HKMPY
From Motley Fool
Hikma receives FDA approval for its generic Vascepa®
Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the... 
From PR Newswire
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
Sedative for patients on ventilators currently in short supply in the US 
From PR Newswire
Hikma launches employee matching donation campaign to support local US food banks and pantries
Campaign will help address significant increase in demand caused by COVID-19 related job losses and furloughs 
From PR Newswire
Hikma Ventures invests in Altoida, Inc., a predictive digital biomarker company using AI and AR to help predict brain diseases with up to 94% accuracy
Hikma Pharmaceuticals PLC announces that its venture capital arm, Hikma Ventures has invested in Altoida, Inc. following the company's $6.3 million Series A round in 2019. 
From PR Newswire
Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
Altoida's FDA-cleared and CE Mark-approved medical device and brain health data platform detects Alzheimer's Disease (AD) up to ten years prior to onset - with up to 94% accuracy 
From PR Newswire
Why Did Amarin's Stock Fall Off a Cliff?
Amarin's stock dropped 70% after its patent for Vascepa was invalidated by a federal judge. 
Tags AMRN Market News HKMPY
From Motley Fool
Amarin Shares Drop 67% As Court Invalidates Its Heart Drug Patent For Vascepa
The shares of Amarin Corporation plc (NASDAQ: AMRN) tanked in the after-hours session on Monday as thecourt ruled against its ... 
Tags General GSK News
From Benzinga
Hikma confirms favourable ruling in generic Vascepa® patent suit
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, today confirms that the United States District Court for the District of Nevada has ruled that Hikma's... 
From PR Newswire
Shares of Amarin Down 68% After Losing a Patent Lawsuit for Vascepa
Judge rules that the patents were obvious. 
Tags HKMPY AMRN GSK
From Motley Fool
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US
Builds on Hikma's leading position in nasal sprays and strong specialty salesforce 
From PR Newswire
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Using Arestat™ Technology
Product designed to provide safer, more immediate treatment option for patients 
From GlobeNewswire News Releases
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
Product designed to provide safer, more immediate treatment option for patients 
From PR Newswire
Up 25% in 2 Months, This Healthcare Stock Could Climb Even Higher
Here is why Jazz Pharmaceuticals could survive the threat from generics for its top-selling product. 
Tags JAZZ Market News HKMPY
From Motley Fool
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday, 224 stocks hit new 52-week highs. Noteables: The largest company by market cap to hit a new 52-week high was ... 
Tags FSUGY XENE BRBR
From Benzinga
Civica Rx and Hikma Announce Shipments of Heparin and Seven Other Essential Injectable Medicines
Civica Rx (Civica, Inc.) and Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P), the multinational generic... 
From Business Wire News Releases
Hikma Ventures leads Series A financing for development of Winterlight Labs' AI vocal technology to detect central nervous system disorders and track efficacy of treatments
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) announces that its venture capital arm, Hikma Ventures has led a CAD 5.6 million... 
From PR Newswire
Hikma launches prefilled syringes in the US
Heparin Sodium Injection in a ready-to-use syringe is the first product using Hikma's new injectable manufacturing capability 
From PR Newswire
Hikma and Civica Rx sign long-term agreement to reduce generic drug shortages in the US
Partnership will supply 14 essential medicines to US hospitals and patients 
From PR Newswire
Hikma Ventures participates in $11 million funding round for Pillo Health
Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) today announced its venture capital arm Hikma Ventures has participated in an... 
From PR Newswire
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home
Pillo Health, a Boston-based technology company improving longevity and quality of life for patients managing their health at home, today announced that is has secured $11 million in funding from... 
From PR Newswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.